Please provide your email address to receive an email when new articles are posted on . Increases in generalized and visceral adipose tissue were linked to reduction of cognitive function in adults, ...
The open-label study evaluated the safety and tolerability, biological activity, blood biomarkers and preliminary efficacy of COYA 301 in 8 patients with Alzheimer’s disease (AD). The ...
The start-up Function will send practically anyone to a lab for extensive medical testing, no physical required. Is that a ...
A study published Monday by scientists at UC San Diego School of Medicine adds to existing research linking physical activity with cognition -- using 90 middle-aged and older subjects who wore ...
Please provide your email address to receive an email when new articles are posted on . Data were derived from Almeida DQ, et al. Eur Respir J. 2022;doi:10.1183 ...
While amyloid β plaques are hallmarks of Alzheimer’s disease (AD), recent research suggests that they aren’t the only players in the neurodegenerative disorder. Genome-wide association studies and RNA ...
At 52 weeks, 100% of subjects (n=4) showed over 30% improvement in pain and function. No serious adverse events or dose-limiting toxicity were reported at 26 to 52 weeks. Ready to turn the market’s ...
Rheumatoid arthritis can negatively affect the liver due to inflammation and autoimmune activity, as well as from the medications used to treat it, but many people with RA and liver involvement may ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback